Jessica Minkue Mi Edou

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Flora Peyvandi, Spero R. Cataland, Marie Scully et al. · Blood Advances · 2021 · 80 citations · Full text

Medicine, Hematology, Pharmacology +7

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

Paul Knoebl, Spero R. Cataland, Flora Peyvandi et al. · Journal of Thrombosis and Haemostasis · 2019 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study

Marie Scully, Javier de la Rubia, Katerina Pavenski et al. · Journal of Thrombosis and Haemostasis · 2022 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14